摘要
本研究观察了１２０例颈内动脉系统急性缺血性脑血管疾病患者，按单双数随机分入激光综合治疗组（激光组）和常规药物治疗组（药物组）各６０例。均予静脉点滴通脉液５００ｍｌ，川芎嗪１００ｍｇ，每天一次，十天为一疗程，激光组同时予１ＬＬＬ１治疗，照射时间６０分钟，每天一次，十天为一疗程，光纤末端输出功率１．５－２．０ｍＷ，同时予３０例健康志愿者１ＬＬＬ１一次。所有受试者在治疗前后均进行血液流变学指标，纤溶系统指标和ＴＣＤ检测，并评定患者治疗５、１０天的疗效。研究结果证明，１ＬＬＬ１ＩＴ可以提高单一药物治疗的疗效，机制是改善血液流变学性能，改善微循环，增快脑血流速度，而且可能有激活纤溶系统功能的作用。所有接受１ＬＬＬＩＴ者均无明显的不良反应。本临床研究表明，１ＬＬＬＩＴ可作为缺血性脑血管病一项有效的安全的辅助治疗方法。
In the present study 120 patients with acute ICVD were randomly divided into common used drug group(drug group,60 cases),which was given Dextron 500 ml and Ligustrazin phosphiatis 100 mg intravenously once a day totally for 10 days and laser combined group (laser group,60 cases),which was given common used drug and ILLLI daily for 10days(each procedure lasted 60minat output end power of 1 5 2 0 mW)Laboratory investigate including hemorheologic test,activity of fibrinolytic system and TCD were performed dynamically in each group of patients as well as in 30 health volunteers who received ILLLI therapy one time The efficacy of patients was evaluated after 5th and 10th treatment The result showed that ILLLI combained therapy could improved the effect resulting from common used drugs in the patients with acute ICVD the machanism is ILLLI can improve the hemorheologic characteristics and microcirculation,increase the cerebral blood flow in the patients with acute ICVD Activity of fibrinolytic system may be stimulated by ILLLI as well No significant side effect was found in all person who received ILLLI ILLLI therapy may be regarded as a effective and safe adjustment therapy for patients with acute ICVD
出处
《激光生物学报》
CAS
CSCD
1998年第1期64-68,共5页
Acta Laser Biology Sinica
关键词
氦氖激光
激光疗法
血管内照射
缺血性脑血管病
Intravascular Low reaction Level He Ne Laser Irradiation Therapy Ischemic cerebrovascular disease Treatment Mechanism
